“Our development actually changes the world of therapeutic antibodies."
By Jewish News Syndicate (JNS)
The research discovered an increase in antibodies in the blood and in breast milk 14 days after the first shot and seven days after the second.
Tel Aviv University researchers have developed a biological substitute for the treatment of tuberculosis, which in the future could serve as an alternative for the traditional "chemical" antibiotic therapy.
By Aryeh Savir, Tazpit News Agency
"The vaccine will protect better than infection with the disease itself.”
“I was made aware that I could donate plasma and that this would help save the lives of others who are suffering from this terrible disease,” Beer said on Sunday.
The patent, approved in March, covers a vaccine that targets the most vulnerable point in a coronavirus’s structure, through which it penetrates human cells
By Jewish News Syndicate (JNS)
Antibody levels will be studied by medical professionals from Albert Einstein College of Medicine and Montefiore Medical Center.
If Dr. Lichtenstein’s research pans out, patients with Alzheimer’s and Parkinson’s might also benefit.